"label","uuid:ID","id","description","instanceType","text","name"
"","2511405a-bd4f-43f2-89d4-a30f0ed4b2a5","Objective_1","Main objective","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJ1"
"","27109ee8-996f-44bf-b060-d3b7eb10b477","Objective_2","Safety","OBJECTIVE","To document the safety profile of the xanomeline TTS.","OBJ2"
"","9a65bc54-20d1-4d4f-816b-f73e1873d251","Objective_3","Behaviour","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJ3"
